MEET OUR PARTNERS

Thank you to our Conference Partners for your support of the NZHPA Conference 2024.


MAJOR CONFERENCE PARTNER

Breakthroughs that change patients’ lives

Throughout Pfizer's 175-year history, we have remained dedicated to discovering and developing new and better ways to prevent and treat disease and improve the health and wellbeing of people around the world.

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development, and manufacturing of medicines. Our diversified global health care portfolio includes human biologic and small molecule medicines and vaccines.

Learn more at www.pfizer.co.nz


CONFERENCE SUPPORTER

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD has 65,000 employees and a presence in virtually every country around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. 

Learn more at bd.com


Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 50,800 people in 80 countries and markets its products in around 170 countries.

Learn more at www.novonordisk.co.nz


CONFERENCE APP PARTNER

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. In Australia and New Zealand, we have approved medicines that treat the underlying cause of cystic fibrosis. We continue to advance clinical and research programs in a number of other disease areas where we have deep insight into causal human biology.

Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognised as one of the industry's top places to work, including 14 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For.

Learn more at www.vrtx.com/en-au/


CONFERENCE CONTRIBUTOR



Pharmac’s job is to get the best health outcomes from treatments for New Zealanders, while staying within the fixed budget the Government sets.

We work closely with health professionals, researchers, and patient groups to support equitable healthcare for all New Zealanders by improving access to medicines, vaccines, medical devices, and related products.

Learn more at www.pharmac.govt.nz




For all conference enquiries please contact our partner:

Rachelle Bertram
Project Coordinator

  rachelle@fp2.co.nz 
  +64 21 027 27073


Paula Armstrong
Project Manager

  paula@fp2.co.nz
  +64 27 649 2081